AJMC Staff

The product, lonapegsomatropin, is a sustained-release formulation and could replace daily injections.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The Supreme Court rules to allow Texas to keep strict abortion law; the family behind Purdue Pharma has been granted immunity from future lawsuits related to the opioid crisis; Pfizer and Merck start trials for oral COVID-19 drugs.

A new Texas law ending abortions after 6 weeks takes effect, angering the American College of Obstetricians and Gynecologists; the CDC says mortality rates may not go back to normal until 2023; a Senate version of a bill aimed at lowering drug prices would only impact Medicare.

HHS establishes the Office of Climate Change and Health Equity; Johnson & Johnson HIV vaccine fails mid-stage trial in sub-Saharan African women; prevalence of overweight and obesity increases significantly in children and adolescents amid the COVID-19 pandemic.

Two people dead after receiving potentially contaminated Moderna COVID-19 vaccines in Japan; Biogen offers its controversial and expensive Alzheimer disease treatment for free to boost prescriptions; COVID-19 infection with the Delta variant may more than double the risk of hospitalization.

FDA halts sale of more than 50,000 flavored e-cigarette products; health systems in Idaho and Oregon struggle to meet the influx of patients with COVID-19; drop in breast cancer screening rates seen throughout pandemic.

Delta Air Lines raises health insurance premiums for employees not vaccinated against COVID-19; the Pentagon requires all active-duty service members to receive a COVID-19 vaccine; 2 mental health giants merge into 1 company worth $3 billion.

Delta variant lowers COVID-19 vaccine effectiveness to 66%; Johnson & Johnson reports booster shot results; cancer center reports mask, vaccine preferences of patients.

Experts update timetable of COVID-19 vaccine trials for children under 12; vaccine mandates happen nationwide in wake of the Pfizer/BioNTech approval; sedentary behavior is associated with 7-fold increased risk of stroke.

COVID-19 booster associated with significantly improved protection against infection in at-risk adults aged 60 and older; spotlighting health risks of climate change for farmworkers; uninsured rate remains stable despite pandemic.

Medical experts express concern over the Biden administration's plan to administer boosters to the general public; US sees increases in vaccination rates and COVID-19 deaths; the CEO of Johnson & Johnson (J&J) will step down in January 2022.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

President Joe Biden pushes back against governors banning school mask mandates; family behind Purdue Pharma refuses to pay settlement for opioid suit without legal protections; the Environmental Protection Agency (EPA) bans a pesticide linked to health issues in children.

Some hospitals may revisit crisis standards of care; Florida hospitals to pause elective surgeries; studies find nearly a quarter of Black Americans with low incomes report fair or poor health care.

US health experts to recommend coronavirus vaccine booster shots for all Americans 8 months after receiving their second dose; 5 states report record 7-day averages of new daily cases of COVID-19; debunking concerns of people receiving blood transfusions from vaccinated individuals.

The breast cancer drug palbociclib may be able to treat myelofibrosis either alone or in combination with ruxolitinib.

The Biden administration announces the largest permanent increase in SNAP benefits history; a potential decision timeline on whether to offer COVID-19 booster shots to Americans may be on the horizon; children hospitalized with COVID-19 reaches a new record high.

A meta-analysis showed adding trastuzumab to chemotherapy for the treatment of early-stage, HER2-positive breast cancer could cut deaths worldwide; a researcher discusses the promise of enfortumab vedotin for advanced urothelial cancers; more research is needed in rare genomic alterations in subsets of colorectal cancer (CRC).

The authors called for screening women for diabetes during pregnancy.

President Joe Biden pushes for measures aimed at lowering drug prices; the Supreme Court allows a vaccine mandate imposed by Indiana University to stand; heat advisories issued for almost 200 million Americans.

The FDA is expected to authorize a third dose of the Pfizer-BioNTech and Moderna COVID-19 vaccines for immunocompromised patients; the CDC revised its COVID-19 vaccine guidance to include pregnant individuals; the FDA issued a complete response letter for the once-anticipated anemia drug roxadustat.

Late July brings a 64% enrollment increase; owner charged with fraudulently billing Medicare over $784 million; COVID-19 hot spots lose nurses due to burnout.

Department of Defense details plan on a COVID-19 vaccine mandate for all active-duty personnel; United Nations climate change report addresses likelihood of future extreme weather events tied to global warming; Government Accountability Office report finds greater readmission risk in understaffed skilled nursing facilities.

Anthony Fauci, MD, addresses potential vaccine mandates once COVID-19 vaccines gain full approval; the FDA issues finalized guidance on using a metastasis-free survival end point in clinical trials of patients with prostate cancer; spotlighting the threat of variant spread and mutation amid case surges nationwide.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

FDA is expected to recommend a plan on distribution of COVID-19 booster shots to immunocompromised Americans; California becomes the first state to issue a vaccine mandate for its health care workers; exploring the threat of COVID-19 infection in pediatric populations.

The Biden administration looks into requiring foreign visitors to be fully vaccinated against COVID-19; subsidies generated from the American Rescue Plan led to savings on premiums for coverage through the Affordable Care Act (ACA); a federal review is under way on the controversial approval of the Alzheimer drug aducanumab (Aduhelm).

FDA reportedly aims to fully approve Pfizer-BioNTech COVID-19 vaccine by early next month; Biogen’s Alzheimer drug sees little uptake; majority of Americans over 65 have received at least 1 dose of a COVID-19 vaccine.

Seventy percent of Americans have received at least 1 dose of a COVID-19 vaccine; CMS releases payment rules for fiscal year 2022; alcohol linked to over 700,000 new cancer diagnoses in 2020.